Your browser doesn't support javascript.
loading
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.
Wichmann, Christian W; Poniger, Stan; Guo, Nancy; Roselt, Peter; Rudd, Stacey E; Donnelly, Paul S; Blyth, Benjamin; Van Zuylekom, Jessica; Rigopoulos, Angela; Burvenich, Ingrid J G; Morandeau, Laurence; Mohamed, Shifaza; Nowak, Anna K; Hegi-Johnson, Fiona; MacManus, Michael; Scott, Andrew M.
Afiliación
  • Wichmann CW; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; School of Chemistry and Bio21 Molecular Science a
  • Poniger S; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; iPHASE technologies Pty Ltd, Rowville, VIC 3178, Australia.
  • Guo N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • Roselt P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Rudd SE; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3052, Australia.
  • Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3052, Australia.
  • Blyth B; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Van Zuylekom J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Rigopoulos A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • Burvenich IJG; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia.
  • Morandeau L; Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
  • Mohamed S; Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
  • Nowak AK; Office of Deputy Vice Chancellor (Research), University of Western Australia, Crawley, WA 6009, Australia.
  • Hegi-Johnson F; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • MacManus M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Scott AM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; Faculty of Medicine, The University of Melbourne,
Nucl Med Biol ; 120-121: 108351, 2023.
Article en En | MEDLINE | ID: mdl-37224789
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Animals / Humans Idioma: En Revista: Nucl Med Biol Asunto de la revista: BIOLOGIA / MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Tipo de estudio: Clinical_trials / Guideline Límite: Animals / Humans Idioma: En Revista: Nucl Med Biol Asunto de la revista: BIOLOGIA / MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article